Both in vitro and in vivo studies indicate that wild-type RAC1 has an essential role in RAS-mediated transformation [109], and RAC1 overexpression is linked to worse prognosis in cancer patients [78,110–112]. This evidence concerns the gene RAC1 and cancer.